Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026

WiseGuyReports.Com Publish a New Market Research Report On –“ Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026”.

Pune, India - April 15, 2019 /MarketersMedia/ —

Gene Therapy Industry 2019

Description:-

The global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need. Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3695595-the-future-of-global-gene-therapy-market-to

For more information or any query mail at sales@wiseguyreports.com

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.
Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3695595-the-future-of-global-gene-therapy-market-to

Table Of Contents – Major Key Points

1. Gene Therapy Overview
1.1. History and Evolution of Gene Therapies
1.2. What is Gene Therapy
1.3. Types of Gene Therapy
1.4. Ex vivo and in vivo Approaches of Gene Therapy
1.5. RNAi Therapeutics
1.6. CAR-T Technology based Gene Therapy
1.7. Types of Vectors used for Gene Therapy
1.7.1. Viral
1.7.2. Non-Viral

2. Historical Marketed Gene Therapies [2003-2012]
2.1. Rexin-G (Epeius Biotechnologies Corporation)
2.2. Gendicine (SiBiono GeneTech Co., Ltd)
2.3. Neovasculgen [Human Stem Cells Institute (HSCI))
2.4. Glybera (UniQure Biopharma B.V.)

3. First Countries to get an access to Gene Therapies
3.1. Philippines for Rexin-G [2003]
3.2. China for Gendicine [2003]
3.3. Russia for Neovasculgen [2011]
3.4. Selected European Countries for Glybera [2012]

4. Marketed Gene Therapies [Approved in Recent Years]
4.1. KYMRIAH (tisagenlecleucel)
4.1.1. Therapy Description
4.1.2. Therapy Profile
4.1.2.1. Company
4.1.2.2. Approval Date
4.1.2.3. Mechanism of Action
4.1.2.4. Researched Indication
4.1.2.5. Vector Used
4.1.2.6. Vector Type
4.1.2.7. Technology
4.1.2.8. Others Development Activities
4.1.3. KYMRIAH Revenue Forecasted till 2021
4.2. YESCARTA (axicabtagene ciloleucel)
4.2.1. Therapy Description
4.2.2. Therapy Profile
4.2.2.1. Company
4.2.2.2. Approval Date
4.2.2.3. Mechanism of Action
4.2.2.4. Researched Indication
4.2.2.5. Vector Used
4.2.2.6. Vector Type
4.2.2.7. Technology
4.2.2.8. Others Development Activities
4.2.3. YESCARTA Revenue Forecasted till 2021
4.3. LUXTURNA (voretigene neparvovec-rzyl)
4.3.1. Therapy Description
4.3.2. Therapy Profile
4.3.2.1. Company
4.3.2.2. Approval Date
4.3.2.3. Mechanism of Action
4.3.2.4. Researched Indication
4.3.2.5. Vector Used
4.3.2.6. Vector Type
4.3.2.7. Technology
4.3.2.8. Others Development Activities
4.3.3. LUXTURNA Revenue Forecasted till 2021
4.4. STRIMVELIS
4.4.1. Therapy Description
4.4.2. Therapy Profile
4.4.2.1. Company
4.4.2.2. Approval Date
4.4.2.3. Mechanism of Action
4.4.2.4. Researched Indication
4.4.2.5. Vector Used
4.4.2.6. Vector Type
4.4.2.7. Technology
4.4.2.8. Others Development Activities
4.4.3. STRIMVELIS Revenue Forecasted till 2021

5. Comparison of current Regulatory Status for Gene Therapy Products
5.1. U.S
5.2. Europe
5.3. Japan

6. Emerging Gene Therapies [Phase III]
6.1. Gene Based Therapeutics under Development
6.2. Therapy Description

7. Indication of Focus in Gene Therapy
7.1. Cancer
7.2. Neurodegenerative Disorders
7.3. Lysosomal Storage Disorders (LSDs)
7.4. Ocular Diseases
7.5. Muscle Disorders
7.6. Anemia
7.7. Hemophilia
7.8. Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3695595

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/gene-therapy-2019-global-market-outlookresearchtrends-and-forecast-to-2026/502768

Source: MarketersMedia

Release ID: 502768

More Press Releases

Puerto Ricans try to forge movement to oust governor

Jul 19, 2019

SAN JUAN, Puerto Rico — Cruise passengers drifted through the streets of Old San Juan Thursday as shop owners took plywood down from store windows and painted over graffiti demanding Gov. Ricardo Rosselló resign. On a colonial plaza behind the governor's mansion, a small group of men and women laid out the shoes of people who died in the aftermath of Hurricane Maria, each decorated with a blue flower. The shoes were first laid out on the steps of the U.S. territory's capitol last year as a protest against government refusal to acknowledge the premature deaths of thousands of people...

Jerry Seinfeld learns from comedy's best on Netflix series

Jul 19, 2019

BEVERLY HILLS, Calif. — Jerry Seinfeld says he'd rather ride classic cars and sip coffee with comedy's best than reboot his uber-successful "Seinfeld" television series. Seinfeld said in an interview Wednesday night that bringing back his eponymous sitcom that recently celebrated its 30-year anniversary would be "egomaniacal." The comedian says he is focused on learning more about the "sharpest minds in comedy" through his Netflix series "Comedians in Cars Getting Coffee." The 11th season premieres Friday on the streaming service featuring Eddie Murphy. The season also includes other comedians including Jamie Foxx, Martin Short, Rick Gervais, Bridget Everett and more....

Rapper YG's home searched after deputy-involved shooting

Jul 19, 2019

LOS ANGELES — Authorities searched the Los Angeles-area home of rapper YG on Thursday in connection with a police shooting in Compton that killed a bystander earlier this month. Deputy Marvin Crowder, a spokesman for the Los Angeles Sheriff's Department, said the rapper, whose real name is Keenon Jackson, has not been implicated in the shooting and was not home at the time of the search Thursday. Crowder said several people were detained Thursday at the Hollywood Hills home but none has been arrested. The fatal shooting occurred July 3 after deputies tried to pull over a Cadillac Escalade —...

Hollywood celebrities open wallets to Buttigieg's campaign

Jul 19, 2019

WASHINGTON — A-list celebrities seem to be opening their hearts — or at least their wallets — to Pete Buttigieg. The South Bend, Indiana, mayor was a virtual unknown months ago. But he used breakout town hall performances, viral moments and his biography as a millennial, gay military veteran and a former Rhodes scholar to get the attention of the entertainment industry and rake in cash. Among the more than 50 celebrities who gave Buttigieg money during the second quarter are rocker Joan Jett ($150), recording industry mogul David Geffen ($5,600), fashion icon Anna Wintour ($2,800), designer Tom Ford ($5,600),...

Sally Field, 'Sesame Street' to receive Kennedy Center award

Jul 19, 2019

WASHINGTON — Actress Sally Field and the long-running children's TV show "Sesame Street" are in the latest class of Kennedy Center Honors recipients. Others chosen to receive the award for lifetime achievement in the arts include singer Linda Ronstadt, conductor Michael Tilson Thomas and the band Earth, Wind and Fire. The co-founders of "Sesame Street," Joan Ganz Cooney and Lloyd Morrisett, will accept the award on behalf of the show. The 42nd annual Kennedy Center Honors Gala will be held Dec. 7. The presenters and performers are usually kept secret from the honorees until the show. The event will be...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Contact us: sales@reppass.com

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases